E M Urbina1, Z Gao, P R Khoury, L J Martin, L M Dolan. 1. Department of Pediatrics, Preventive Cardiology, Cincinnati Children's Hospital Medical Center and the University of Cincinnati, 3333 Burnet Avenue, MLC-7002, Cincinnati, OH 45229, USA. Elaine.Urbina@cchmc.org
Abstract
AIMS/HYPOTHESIS: Increased arterial stiffness is a risk factor for adverse cardiovascular events in adults with obesity-related insulin resistance (IR) or type 2 diabetes mellitus. Adolescents with type 2 diabetes have stiffer vessels. Whether stiffness is increased in obesity/IR in youth is not known. We sought to determine if IR was a determinant of arterial stiffness in youth, independent of obesity and cardiovascular risk factors. METHODS: We measured cardiovascular risk factors, IR, adipocytokines and arterial stiffness (brachial artery distensibility [BrachD], pulse wave velocity [PWV]) and wave reflection (augmentation index [AIx]) in 343 adolescents and young adults without type 2 diabetes (15-28 years old, 47% male, 48% non-white). Individuals <85th percentile of BMI were classified as lean (n = 232). Obese individuals were grouped by HOMA index as not insulin resistant (n = 46) or insulin resistant (n = 65) by the 90th percentile for HOMA for lean. Mean differences were evaluated by ANOVA. Multivariate models evaluated whether HOMA was an independent determinant of arterial stiffness. RESULTS: Risk factors deteriorated from lean to obese to obese/insulin resistant (all p ≤ 0.017). Higher AIx, lower BrachD and higher PWV indicated increased arterial stiffness in obese and obese/insulin-resistant participants. HOMA was not an independent determinant. Age, sex, BMI and BP were the most consistent determinants, with HDL-cholesterol playing a role for BrachD and leptin for PWV (AIx R²= 0.34; BrachD R² = 0.37; PWV R² = 0.40; all p ≤ 0.02). CONCLUSIONS/ INTERPRETATION: Although IR is associated with increased arterial stiffness, traditional cardiovascular risk factors, especially obesity and BP, are the major determinants of arterial stiffness in healthy young people.
AIMS/HYPOTHESIS: Increased arterial stiffness is a risk factor for adverse cardiovascular events in adults with obesity-related insulin resistance (IR) or type 2 diabetes mellitus. Adolescents with type 2 diabetes have stiffer vessels. Whether stiffness is increased in obesity/IR in youth is not known. We sought to determine if IR was a determinant of arterial stiffness in youth, independent of obesity and cardiovascular risk factors. METHODS: We measured cardiovascular risk factors, IR, adipocytokines and arterial stiffness (brachial artery distensibility [BrachD], pulse wave velocity [PWV]) and wave reflection (augmentation index [AIx]) in 343 adolescents and young adults without type 2 diabetes (15-28 years old, 47% male, 48% non-white). Individuals <85th percentile of BMI were classified as lean (n = 232). Obese individuals were grouped by HOMA index as not insulin resistant (n = 46) or insulin resistant (n = 65) by the 90th percentile for HOMA for lean. Mean differences were evaluated by ANOVA. Multivariate models evaluated whether HOMA was an independent determinant of arterial stiffness. RESULTS: Risk factors deteriorated from lean to obese to obese/insulin resistant (all p ≤ 0.017). Higher AIx, lower BrachD and higher PWV indicated increased arterial stiffness in obese and obese/insulin-resistant participants. HOMA was not an independent determinant. Age, sex, BMI and BP were the most consistent determinants, with HDL-cholesterol playing a role for BrachD and leptin for PWV (AIx R²= 0.34; BrachD R² = 0.37; PWV R² = 0.40; all p ≤ 0.02). CONCLUSIONS/ INTERPRETATION: Although IR is associated with increased arterial stiffness, traditional cardiovascular risk factors, especially obesity and BP, are the major determinants of arterial stiffness in healthy young people.
Authors: Elaine M Urbina; Thomas R Kimball; Philip R Khoury; Stephen R Daniels; Lawrence M Dolan Journal: J Hypertens Date: 2010-08 Impact factor: 4.844
Authors: P H Whincup; J A Gilg; A E Donald; M Katterhorn; C Oliver; D G Cook; J E Deanfield Journal: Circulation Date: 2005-09-20 Impact factor: 29.690
Authors: Heikki Aatola; Nina Hutri-Kähönen; Markus Juonala; Jorma S A Viikari; Janne Hulkkonen; Tomi Laitinen; Leena Taittonen; Terho Lehtimäki; Olli T Raitakari; Mika Kähönen Journal: Hypertension Date: 2010-01-18 Impact factor: 10.190
Authors: Athanase D Protogerou; Jacques Blacher; Elisabeth Aslangul; Claire Le Jeunne; John Lekakis; Myron Mavrikakis; Michel E Safar Journal: Atherosclerosis Date: 2006-06-27 Impact factor: 5.162
Authors: Pantelis E Zebekakis; Tim Nawrot; Lutgarde Thijs; Elisabeth J Balkestein; Janneke van der Heijden-Spek; Luc M Van Bortel; Harry A Struijker-Boudier; Michel E Safar; Jan A Staessen Journal: J Hypertens Date: 2005-10 Impact factor: 4.844
Authors: Ronald M A Henry; Piet J Kostense; Annemieke M W Spijkerman; Jacqueline M Dekker; Giel Nijpels; Robert J Heine; Otto Kamp; Nico Westerhof; Lex M Bouter; Coen D A Stehouwer Journal: Circulation Date: 2003-04-14 Impact factor: 29.690
Authors: Jeremy P Loenneke; Christopher A Fahs; Kevin S Heffernan; Lindy M Rossow; Robert S Thiebaud; Michael G Bemben Journal: Eur J Appl Physiol Date: 2012-07-06 Impact factor: 3.078
Authors: Thomas D Ryan; John J Parent; Zhiqian Gao; Philip R Khoury; Elizabeth Dupont; Jennifer N Smith; Brenda Wong; Elaine M Urbina; John L Jefferies Journal: Pediatr Cardiol Date: 2017-06-21 Impact factor: 1.655
Authors: Stacey Alvarez-Alvarado; Salvador J Jaime; Michael J Ormsbee; Jeremiah C Campbell; Joy Post; Jacob Pacilio; Arturo Figueroa Journal: Hypertens Res Date: 2017-01-12 Impact factor: 3.872
Authors: Benard O Ogola; Margaret A Zimmerman; Gabrielle L Clark; Caleb M Abshire; Kaylee M Gentry; Kristin S Miller; Sarah H Lindsey Journal: Am J Physiol Heart Circ Physiol Date: 2018-07-20 Impact factor: 4.733
Authors: Brie M Reid; Michelle M Harbin; Jessica L Arend; Aaron S Kelly; Donald R Dengel; Megan R Gunnar Journal: J Pediatr Date: 2018-08-23 Impact factor: 4.406